Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025

Same author

Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.

The New England journal of medicine·2023

Same author

Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.

Nature communications·2022

Same author

Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial.

Clinical lung cancer·2021

Same author

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.

Nature communications·2021

Same author

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants.

Blood cancer journal·2021

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Acute leukemia in women.

Francesco Lo-Coco¹, Tamer M Fouad, Safaa M Ramadan

¹Department of Biopathology, University of TorVergata, Rome, Italy. francesco.lo.coco@uniroma2.it

Women'S Health (London, England)

|March 2, 2010

Summary

Acute leukemia outcomes are similar for men and women, but women face unique challenges during treatment and survivorship. This includes managing bleeding risks, pregnancy, and long-term health issues.

Area of Science:

Hematology
Oncology
Women's Health

Background:

Acute leukemia treatment and survival rates are comparable between men and women.
However, specific considerations for women require attention in clinical practice.

Purpose of the Study:

To review the unique challenges in treating acute leukemia in women.
To discuss health and psychosocial issues faced by female survivors, including those with a history of breast and ovarian cancer.

Main Methods:

This is a review article.
It synthesizes existing literature on acute leukemia in women.

Main Results:

Women with acute leukemia require specific precautions, such as managing abnormal uterine bleeding and considering pregnancy.

Related Experiment Videos

Last Updated: Jun 15, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Female survivors face distinct long-term health and psychosocial challenges.

Therapy-related acute leukemia is a concern for women with prior breast and ovarian cancer.

Conclusions:

Addressing the unique aspects of acute leukemia in women is crucial for optimal care.
Long-term follow-up and support are essential for female survivors of childhood leukemia.
Survivors of breast and ovarian cancer require careful monitoring for therapy-related acute leukemia.